Financial Ratios

WOCKHARDT LTD.

NSE : WOCKPHARMABSE : 532300ISIN CODE : INE049B01025Industry : Pharmaceuticals & DrugsHouse : Wockhardt
BSE545.009.75 (+1.82 %)
PREV CLOSE ( ) 535.25
OPEN PRICE ( ) 540.00
BID PRICE (QTY) 545.00 (1000)
OFFER PRICE (QTY) 546.00 (10)
VOLUME 24989
TODAY'S LOW / HIGH ( )530.65 554.00
52 WK LOW / HIGH ( )145.35 630
NSE543.009.45 (+1.77 %)
PREV CLOSE( ) 533.55
OPEN PRICE ( ) 543.90
BID PRICE (QTY) 541.50 (56)
OFFER PRICE (QTY) 543.00 (56)
VOLUME 230745
TODAY'S LOW / HIGH( ) 540.00 554.00
52 WK LOW / HIGH ( )145.15 630
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-32.36-9.72-35.64-29.41-15.99
   CEPS(Rs)-19.442.15-17.43-12.67-4.76
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)120.63152.36143.4587.11107.91
   Tax Rate(%)9.1623.9137.0832.6744.97
Margin Ratios
   Core EBITDA Margin(%)6.5216.15-13.93-19.77-4.22
   EBIT Margin(%)-26.446.47-42.68-29.61-9.68
   Pre Tax Margin(%)-47.77-13.38-62.87-54.34-20.65
   PAT Margin (%)-43.39-10.18-39.56-36.59-11.37
   Cash Profit Margin (%)-26.072.25-20.99-17.11-3.67
Performance Ratios
   ROA(%)-9.25-2.71-8.47-7.31-4.05
   ROE(%)-23.71-7.42-30.83-30.17-14.44
   ROCE(%)-7.922.54-13.89-8.81-4.88
   Asset Turnover(x)0.210.270.210.200.36
   Sales/Fixed Asset(x)0.320.420.310.290.60
   Working Capital/Sales(x)-0.81-1.71-1.09-1.22707.91
Efficiency Ratios
   Fixed Capital/Sales(x)3.162.373.243.401.66
   Receivable days313.17298.24348.92398.74211.49
   Inventory Days127.4497.55126.94145.8587.55
   Payable days518.37378.42407.71665.89279.97
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)-7.92122.54-21.91-12.56-85.72
   Price/Book(x)1.281.732.891.984.11
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)3.543.786.114.084.21
   EV/Core EBITDA(x)27.7419.93-62.19-40.29-211.94
   EV/EBIT(x)-13.3858.22-14.26-13.78-43.52
   EV/CE(x)0.850.931.270.801.49
   M Cap / Sales2.072.774.622.153.15
Growth Ratio
   Net Sales Growth(%)-21.8739.0110.89-42.85-37.13
   Core EBITDA Growth(%)-47.31368.04-7.63-191.09-108.15
   EBIT Growth(%)-419.10121.04-60.53-74.76-155.13
   PAT Growth(%)-232.8664.29-20.36-83.98-357.82
   EPS Growth(%)-232.8672.72-21.17-83.88-357.73
Financial Stability Ratios
   Total Debt/Equity(x)0.930.721.021.941.58
   Current Ratio(x)0.490.740.650.681.00
   Quick Ratio(x)0.360.610.520.540.80
   Interest Cover(x)-1.240.33-2.12-1.20-0.88
   Total Debt/Mcap(x)0.730.420.350.980.38

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.